Invention Grant
- Patent Title: Solid forms comprising an oxime ether compound and a coformer, compositions and methods of use thereof
-
Application No.: US16905441Application Date: 2020-06-18
-
Publication No.: US11434200B2Publication Date: 2022-09-06
- Inventor: Lianfeng Huang , Daozhong Zou
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
- Main IPC: C07D205/04
- IPC: C07D205/04 ; A61K47/22 ; A61K9/48 ; A61K9/20 ; A61K47/10
Abstract:
Provided herein are formulations, processes, solid forms and methods of use relating to (E)-1-(4-(1-(((4-cyclohexyl-3-(trifluoromethyl)benzyl)oxy)imino)ethyl)-2-ethylbenzyl)azetidine-3-carboxylic acid.
Public/Granted literature
- US20210139420A1 Solid Forms Comprising an Oxime Ether Compound and a Coformer, Compositions and Methods of Use Thereof Public/Granted day:2021-05-13
Information query
